Aim immunotech announces release of the next ceo corner segment

Ocala, fla., april 18, 2024 (globe newswire) -- aim immunotech inc. (nyse american: aim) (“aim” or the “company”), today announced the next ceo corner segment has been published on the company's website. for the ceo corner segment, thomas equels, chief executive officer of aim immunotech, gave an overview of locally advanced pancreatic adenocarcinoma and the unmet need.
AIM Ratings Summary
AIM Quant Ranking